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Abstract 
 
Background/Aim. Since skin moisturization may be 
achieved by both actives and chosen carrier, plant stem 
cells, squalene and natural alkyl polyglucoside emulsifier 
may be potential components of contemporary cosmetic 
products. The aim of the study was in vivo evaluation of the 
skin irritation potential and the efficacy of Alpine Rose stem 
cells incorporated into liposomes and olive oil squalene as 
ingredients of moisturizing creams, with respect to the 
novel emulsifier used for creams’ stabilization. Methods. 
With the employment of noninvasive skin biophysical 
measurements, skin hydration (EC), transepidermal water 
loss (TEWL), erythema index (EI) and viscoelasticity were 
measured on 76 healthy volunteers. In the first phase, skin 
irritation after a 24-hour occlusion and the long-term effi-
cacy of creams (a 21-day study) on healthy skin were evalu-
ated. Phase II of the study focused on the cream efficacy as-
sessment after a 6-day treatment of sodium lauryl sulfate-
irritated skin. Results. After a 24-hour occlusion, there 
were no significant changes in the EI for any tested sample. 
In the second phase of the study, the EI was not signifi-
cantly altered for the cream containing squalene, while the 
application of all active samples resulted in a significant re-
duction of TEWL. In both phases of the study an EC in-
crease was recorded, especially for the squalene-containing 
cream. Conclusion. Due to the lack of skin irritation and 
skin barrier impairment along with the marked hydration ef-
fect, it could be said that the investigated actives incorpo-
rated into alkyl polyglucoside emulsifier-stabilized creams 
may be safely applied as ingredients for "tailor-made" cos-
metic moisturizers intended for normal and dry skin care, 
whereas olive oil squalene could be used for the treatment 
of irritated or sensitive skin as well. 
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Apstrakt 
 
Uvod/Cilj. S obzirom na to da vlaženje kože može biti 
postignuto izborom kako aktivnih supstanci, tako i 
odgovarajućeg nosača, biljne matične ćelije, skvalen i pri-
rodni alkil poliglukozidni emulgator mogu biti potencijalni 
sastojci savremenih kozmetičkih proizvoda. Cilj ovog rada 
bio je in vivo procena iritiranog potencijala i efikasnosti 
matičnih ćelija alpske ruže dodatih u liposome i skvalena 
maslinovog ulja, kao sastojaka vlažećih krema, imajući u 
vidu nov emulgator koji je korišćen za njihovu stabili-
zaciju. Metode. Upotrebom neinvazivnih metoda zasno-
vanih na biofizičkim merenjima na koži, kod 76 zdravih 
dobrovoljaca mereni su: hidratacija kože (EC), transepi-
dermalni gubitak vlage (TEWL), eritema indeks (EI) i 
viskoelastičnost kože. U prvoj fazi studije vršena je pro-
cena iritacije kože nakon 24-h okluzije, kao i procena efi-
kasnosti krema nakon primene na zdravoj koži dobrovol-
jaca u trajanju od 21 dana. Druga faza studije bila je ba-
zirana na proceni efikasnosti krema nakon 6-dnevnog 
tretmana kože prethodno iritirane natrijum-lauril-sulfatom. 
Rezultati. Nakon 24-h okluzije nije bilo značajne 
promene vrednosti EI ni kod jednog ispitivanog krema. U 
drugoj fazi studije, krem sa skvalenom nije značajno uticao 
Page 992 VOJNOSANITETSKI PREGLED Vol. 73, No. 11 
Filipović M, et al. Vojnosanit Pregl 2016; 73(11): 991–1002. 
na promenu vrednosti EI, dok je primena svih aktivnih 
krema dovela do značajnog sniženja vrednosti TEWL. U 
obe faze studije zabeležen je porast EC, naročito nakon 
primene krema koji sadrži skvalen. Zaključak. Uzevši u 
obzir odsustvo nadraženosti kože i narušavanja kožne 
barijere, kao i porast hidratacije površinskog sloja kože, 
može se reći da se ispitivane aktivne supstance ubačene u 
kreme stabilizovane alkil-poliglukozidnim emulgatorom 
mogu bezbedno koristiti kao komponente tzv. „skrojenih“ 
kozmetičkih ovlaživača namenjenih za negu zdrave i suve 
kože, dok se skvalen maslinovog ulja može koristiti i za 
negu iritirane i osetljive kože. 
 
Ključne reči: 
ekstrakti, biljni; ćelije, matične; kozmetička sredstva; 
koža; skvalen; emulzije; koža, iritacija, testovi. 
 
Introduction 
Moisturizers play an important role in healthy skin care, 
as well as in treatment of dermatoses accompanied with dry 
skin. In addition to moisturizing and preventing dryness, they 
may also influence the structure and barrier function of both 
healthy and diseased skin 1, 2. With long-term daily use, de-
pending on their composition, moisturizers may either im-
prove or deteriorate skin barrier function, and consequently 
increase penetration of ingredients in/through the skin and 
cause (further) skin dryness and irritation 1–3. Therefore, with 
the appropriate formulation and ingredient selection it is pos-
sible to achieve the preferred effect of topical preparations 
on the structure and barrier function of healthy or diseased 
skin in terms of skin hydration, while also repairing the skin 
barrier and reducing the signs of its irritation. 
Plant stem cells, though interesting, are not sufficiently 
investigated as cosmetic actives. They represent extracts of 
the whole cell culture containing all the important compo-
unds–epigenetic factors and secondary metabolites signifi-
cant for protection and maintaining of these factors 4. Accor-
ding to the manufacturer, stem cells from the Alpine Rose, 
Rhododendron ferrugineum, possess the ability to increase 
the vitality of epidermal stem cells and protect them against 
UV-induced stress, due to the content of various polyphenols 
and proteins called dehydrins. Furthermore, Alpine Rose 
stem cells (ARSC) are claimed to protect the skin barrier, 
supposedly by making it more resistant to the combination of 
strong environmental stress factors (UV, cold, wind) during 
the winter season. Finally, the anti-wrinkle effect has also 
been attributed to ARSC 5. 
Squalene is naturally present in the sebum and it is one 
of the main constituents of skin surface polyunsaturated li-
pids. The most abundant source of squalene is the shark liver 
oil, although nowadays, as a cosmetic active, squalene is 
exclusively obtained from plant-natural sources (eg olive 
oil). Squalene is used in cosmetics for its emollient, moistu-
rizing and anti-irritant effects, as well as for the repair of skin 
barrier function. Also, it has been reported that squalene pro-
tects skin surface from lipid peroxidation caused by UV light 
and acts as a highly efficient quencher of singlet oxygen, 
which explains its antioxidant properties 6, 7. 
Although the proper selection of emollients and active 
ingredients certainly is the most relevant step towards assu-
ring the desired effect of moisturizing creams, the importan-
ce of the used emulsifier system should not be neglected. 
The applied emulsifier together with the oil phase (emolli-
ents) defines the system’s structure, and, consequently, the 
cream’s behaviour during and after the application, as well as 
its effect on the skin 8. Additionally, certain safety aspects 
are based on the final choice of the emulsifier system 1, 2. 
Alkyl polyglucosides (APGs) are non-ionic, 
polyethylene glycol-free surfactants, derived from natural, 
renewable sources. APGs show favorable dermatological 
properties, ie they are mild to the skin and therefore conside-
red as skin friendly. Furthermore, they are highly valued for 
their biodegradability, and hence frequently labelled as envi-
ronment friendly emulsifiers. The specific chemical structu-
re, water holding capacity and ability to form certain lamellar 
structures similar to the stratum corneum (SC) structural or-
ganization, makes them interesting cosmetic and pharmaceu-
tical raw materials 8–10. A novel APG-mixed emulsifier, 
hydroxystearyl alcohol and hydroxystearyl glucoside (INCI), 
has improved sensory properties and due to the additional 
diol structure in hydrophilic sugar unit, provides significant, 
continuous hydration of the upper layers of the skin 11. To 
the best of our knowledge, there is insufficient data available 
on this natural APG-mixed emulsifier as a potential stabilizer 
of moisturizing creams. 
In accordance with the aforementioned, the aim of this 
study was to investigate in vivo skin irritation as a certain as-
pect of safety, and in vivo skin efficacy of Alp Rose stem 
cells incorporated into liposomes, olive oil squalene and a 
novel natural APG-mixed emulsifier, as ingredients of mois-
turizing creams. Efficacy was evaluated on both normal and 
experimentally irritated skin. 
With that aim, we conducted the two phase study: the 
first phase was performed so as to assess the irritation poten-
tial of the samples after a 24-h occlusion, as well as the long-
term effects of the samples’ daily use in healthy skin care, 
while the second phase was carried out to evaluate the 
efficacy of the samples in the treatment of sodium lauryl sul-
fate (SLS) – irritated skin. 
Methods 
Subjects 
The study was performed in accordance with the Declara-
tion of Helsinki after obtaining written informed consent from 
the volunteers and permission from the Ethical Committee of 
the Faculty of Pharmacy, University of Belgrade, Serbia (the 
approval number: 1583/1). All measurements in this study were 
carried out in accordance with the relevant guidelines 12–15. 
A panel of 76 healthy female volunteers without the 
history or clinical signs of dermatological disease and with 
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Table 1 
Composition of the investigated samples  
Sample*, % (w/w) Ingredients/INCI 
F1p  F1a  F1s F1a1s F1a6s
A (Oil phase)    
caprylic/capric triglyceride 7.0 7.0 7.0 7.0 5.0 
mineral oil 3.5 3.5 3.5 3.5 2.5 
isopropyl myristate 4.5 4.5 4.5 4.5 3.25 
Prunus amygdalus dulcis (sweet almond) seed oil 3.0 3.0 3.0 3.0 2.25 
squalene (Olifeel® SQ)   1.0 1.0 6.0 
B (Water phase)   
INCI (SimulgreenTM 18–2) 5.0 5.0 5.0 5.0 5.0 
glycerin  2.0 2.0 2.0 2.0 2.0 
water ad 100.0 ad 100.0 ad 100.0 ad 100.0 ad 100.0 
C      
xanthan gum 0.5 0.5 0.5 0.5 0.5 
tocopheryl acetate 0.3 0.3 0.3 0.3 0.3 
Rhododendron ferrugineum leaf cell culture extract (and) Isomalt (and) lecithin 
(and) sodium benzoate (and) lactic acid (and) aqua (PhytoCellTec™ Alp rose) 
 0.4  0.4 0.4 
Preservatives blend 0.5 0.5 0.5 0.5 0.5 
INCI – Hydroxystearyl alcohol and Hydroxystearyl glucoside; Alp – alpine. 
*For explanation see Methods (Test samples). 
normal to moderate dry skin participated in the study. The 
type of the skin (normal to moderate dry skin) was evaluated 
thanks to the basal values of the measured parameters, 
primarily on the basis of transepidermal water loss (TEWL) 
values (TEWL values were lower than 12 g/m2h) 1, 16. 
The volunteers were instructed not to use any skin care 
products on their arms a week before and throughout the 
study, but were allowed to wash normally during the study. 
According to the published guidelines, measurements 
were carried out under controlled conditions: temperature 
(21 ± 1°C) and relative humidity (40 ± 5%), after a 30-min 
acclimatization period of the participants 16. 
Materials 
A natural emulsifier of APG type, INCI (Simulgreen™ 18-
2) was kindly provided by Seppic, France. Olive oil squalene 
with 96% purity (Olifeel® SQ) was kindly provided by Amedeo 
Brasca & C. SRL, Italy, and stem cells of Alpine Rose leaves 
encapsulated in liposomes (PhytoCellTec™ Alp Rose) were 
kindly provided by Mibelle AG Biochemistry, Switzerland. Oli-
feel® SQ is clear oily liquid with slight odour, yellow color and 
high purity which prevents degradation and coloring. According 
to the producer statement, it can be easily incorporated in all 
types of cosmetic products. PhytoCellTec™ Alp Rose is powder 
with specific odor, dissolvable up to 20% in water, which can be 
incorporated in all advanced “stem cell cosmetic” formulas, face 
and body care products and every weather formulations 5. 
Other components were: caprylic/capric triglyceride 
(Levate, Italy), Prunus amygdalus dulcis (Sweet Almond) 
seed oil, isopropyl myristate (A&A Fratelli Parodi, Italy) and 
mineral oil (RA.M. Oil S.p.A., Italy). All samples were 
suitably preserved and also contained tocopheryl acetate 
(BASF, Germany) as an antioxidant, glycerin (BASF, 
Germany) as a humectant and Xanthan gum (Gum 
Technology, Arizona) as an additional stabilizer.  
Test samples 
In order to determine the optimal formulation, the number 
of oil in water (O/W) cream samples were prepared containing a 
multi-component oil phase, fixed emulsifier content (5%) and 
different types of the additional stabilizers applied. Also, in or-
der to decrease the number of potential confounding factors, 
cream samples were formulated as simply as possible. Along 
with the placebo samples (creams without the active substan-
ces), the active samples were prepared accordingly. 
Based on the conducted preliminary physical stability 
evaluation, the placebo sample F1p, the active sample F1a 
(cream with ARSC incorporated into liposomes, 0.4% w/w, 
since the recommended use level for this active is 0.4–1% 
w/w) and the active sample F1s (cream with olive oil 
squalene, 1% w/w) were singled out and prepared for the 
subsequent in vivo investigation. 
The fourth sample (Fc) was a commercial cream from the 
market with ARSC incorporated into liposomes (the same 
concentration and the same manufacturer of the active), and 
the following composition: ingredients (INCI)/Aqua, 
propylheptyl caprylate, coco caprylate, dicaprylyl carbonate, 
hydrogenated vegetable glycerides, avocado oil, 
pentaerythrityl distearate, Butyrospermum parkii, ethylhexyl 
methoxycinnamate, diglycerine, imperata cylindrica root 
extract, glycerine, polyethylene glycol (PEG)-8, carbomer, tri-
ceteareth-4 phosphate, ammonium acryloyldimethyl taura-
te/VP copolymer, phenoxyethanol, methylparaben, 
butylparaben, isobutylparaben, ethylparaben, propylparaben, 
tocopheryl acetate, butyl methoxydibenzoylmethane, parfum, 
polysorbate-20, Rhododendron ferrugineum leaf cell culture 
extract, isomalt, lecithin, sodium benzoate, lactic acid, tocop-
herol, ascorbyl palmitate, ascorbic acid, citric acid, disodium 
ethylenediaminetetraacetic (EDTA), linalool, limonene. 
In the second phase of the study two new O/W cream 
samples were introduced instead of the commercial cream: 
the cream sample F1a1s containing the combination of 
ARSC (0.4% w/w) and 1% of olive oil squalene, and the cre-
am sample F1a6s containing the same concentration of 
ARSC but 6% of squalene. The composition of all the prepa-
red samples is given in Table 1. 
Preparation of the formulations 
The oil phase was heated in a closed vessel on the hea-
ting plate of a magnetic stirrer (IKA Combimag RCH, 
Germany) to 70°C. The aqueous phase containing glycerin 
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was heated in a closed vessel to 75°C, when the emulsifier 
was added while stirring (propeller laboratory stirrer, Hei-
dolph Instruments GmbH & Co, Kelheim, Germany) for 1 
min at 1,500 rpm. At the same temperature, the oil phase was 
added to the aqueous phase followed by stirring at 1,500 rpm 
for 5 min. The cream was being gradually cooled for 3 min 
at 1,050 rpm, at 725 rpm for 5 min and further at 1,050 rpm 
to room temperature. Xanthan gum was added in the cooling 
phase of the cream at the temperature below 60°C, while the 
preservatives blend and tocopheryl acetate were incorporated 
at below 40°C. Alp Rose stem cells, previously dispersed in 
5 g of water (this was taken into account after having deter-
mined the needed amount of the aqueous phase), were 
carefully added during the cooling phase of the cream (at a 
temperature below 60°C), after adding of the stabilizer. 
The samples containing squalene did not change their ap-
pearance (namely color or smell) throughout the temperature 
stress tests, after having been stored at room temperature or 
when submitted to the application during the study, which indi-
cated the absence of oxidation products of squalene [eg squalene 
monohydroperoxide (SQOOH), as a main photo-oxidation pro-
duct and a primary UV oxidized lipid produced from squalene] 
6. Temperature stress tests were performed by 24-h preservation 
of samples at three different temperature conditions (4°C, room 
temperature and 40°C), during 6 cycles (18 days). 
Experimental design 
The study was randomized, double-blind and organized 
in two phases. 
In the first phase of the study, 52 volunteers were 
randomly divided into two groups. 
The first group of 16 volunteers (mean age 21.8 ± 3.6) 
participated in the evaluation of irritation potential of cream 
samples under a 24-h occlusion. Samples were applied on the 
volar aspects of the forearms using a precisely marked cardbo-
ard ruler with three empty rectangular spaces (each measuring 
9 cm2, 3 cm × 3 cm). Two samples per arm were applied, and 
a rectangle next to the wrist was left as an untreated control 
(UC) on each forearm. The untreated control on the left arm 
was occluded (untreated control occluded – UCO). After sam-
ples application, the treated sites were immediately covered 
with Parafilm® (Pechiney Plastic Packaging, Inc., Menasha, 
Wisconsin, USA) and cotton adhesive tape Sensifix® (Belgra-
de, Serbia). In this phase of the study the following parameters 
were measured: electrical capacitance (EC), TEWL and 
erythema index (EI), before samples application (baseline va-
lues) and 3 h following the occlusion removal. 
The second group of 36 volunteers (mean age 20.5 ± 
0.5) participated in the evaluation of the efficacy of the same 
samples during their long-term application on the healthy 
skin. The samples were applied on the volar aspects of fore-
arms using the same cardboard ruler and in the same, 
previously described manner. The rectangle closest to the 
wrist on each forearm served as an untreated control. The 
samples were distinguished solely by the color of the packa-
ging. The volunteers received clear instructions regarding the 
sample amount and application manner. They applied sam-
ples to the specific test sites twice a day (in the morning and 
in the evening). In this part of the study EC, TEWL and skin 
elasticity were monitored. The measurements were conduc-
ted before the application of the samples commenced (base-
line values), after a 14-day and subsequently after a 3-week 
treatment. The volunteers were instructed to skip the applica-
tion the morning before the measurement. 
In the second phase of the study, 24 volunteers (mean age 
29.9 ± 8.9) participated in the evaluation of the efficacy of the 
samples in the treatment of SLS-irritated skin. The experimental 
irritation with SLS under a 6-h occlusion was performed in ac-
cordance with the published guidelines 17 and in the previously 
reported manner 18. A total of 100 μL of 10% aqueous solution of 
SLS (purity 99%, Merck, Germany) was placed on each of the 
six filter papers. The filter papers were subsequently placed on 
the test sites of the volar aspects of forearms using a cardboard 
ruler with four rectangular empty spaces in the following man-
ner: three rectangular spaces from the left wrist up and three rec-
tangular spaces from the right elbow down were covered with fil-
ter papers. Then, the filter papers were immediately covered with 
a Parafilm® and cotton adhesive tape Sensifix®. The test site next 
to the left wrist represented the induced UCO, and the rectangular 
empty space next to the right wrist was covered without induced 
irritation and served as an UC. The volunteers removed 
Sensifix®, Parafilm® and the filter papers after 6 h. After irritati-
on, a 6-day treatment of the tested sites was conducted. Five 
samples were applied, two samples to the left and three samples 
to the right hand, twice a day (in the morning and in the evening). 
In this phase of the study the following cream samples were in-
vestigated: F1p, F1a, F1s, and instead of the commercial cream 
(Fc), two new samples were introduced (F1a1s and F1a6s). In 
this part of the study the following parameters were measured: 
EC, TEWL and EI, before the irritation test ("primary" baseline 
values), 24 h after the occlusion removal ("secondary" baseline 
values) and after 6 days of the treatment. The last sample applica-
tion was performed 12 h prior to measurements. 
Corneometer® CM825 was used for skin measurement EC 
as an indicator of skin hydration. TEWL was measured using 
Tewameter® TM210, EI using Mexameter® MX18 and the skin 
elasticity using Cutometer® MPA580 (all devices manufactured 
by Courage + Khazaka Electronic GmbH, Germany). 
Statistical analysis 
All data were presented as mean ± standard error of the 
mean (SEM). Data from different sites (treated with different 
samples including both controls) at different time points 
were analyzed using one-way ANOVA, followed by Tukey's 
t-test where appropriate. The differences were accepted as 
statistically significant at p < 0.05. Statistical analysis was 
performed with commercial statistical software package 
SPSS for Windows 17.0. 
Results 
In the first phase, as well as in the second one, all the 
volunteers completed the study and reported strict complian-
ce with the given instructions. 
Vol. 73, No. 11 VOJNOSANITETSKI PREGLED Page 995 
Filipović M, et al. Vojnosanit Pregl 2016; 73(11): 991–1002. 
 
Fig. 1 – In vivo irritation potential of the investigated 
samples† F1p, F1a, Fc, F1s vs the untreated controls – 
UC: without occlusion (UC) and occluded (UCO). 
The data from different sites was analyzed using one-
way ANOVA, followed by Tukey's test where 
appropriate. Electrical capitance (EC), erythema index 
(EI) and transepidermal water loss (TEWL) for the 
same sample at various time points were compared 
using paired sample t-test (significant changes marked 
with*).  
†For explanation see.  Methods (Test samples). 
 
 
Fig. 2 – The effect of the topical application of the samples† 
F1p, F1a, Fc and F1s on electrical capitance (EC),  
related to the untreated control (percentage change). 
Data involving the values of the parameters measured 
on the forearm skin areas treated by different samples 
was analyzed by the one-way within-subjects (repeated 
measures) ANOVA, followed by Tukey’s t-test, where 
appropriate; differences between the values of the 
parameters obtained for the cream-treated skin and the 
corresponding untreated control were checked by 
Student’s unpaired t-test; all significant differences 
(p < 0.05) being marked with (*). 
  †For explanation see Methods (Test samples). 
Table 2 
The effect of the investigated samples on selected viscoelastic parameters of the skin  
(the control values are also given) 
Samples* R2 R5 R7 R2† R5† R7† 
F1p 0.843 ± 0.036 0.995 ± 0.101 0.649 ± 0.057 0.833 ± 0.041 0.950 ± 0.097 0.621 ± 0.056 
F1a 0.828 ± 0.026 0.921 ± 0.078 0.606 ± 0.039 0.847 ± 0.033 0.955 ± 0.077 0.632 ± 0.046 
UC1 0.813 ± 0.041 0.847 ± 0.081 0.576 ± 0.051 0.806 ± 0.061 0.824 ± 0.094 0.563 ± 0.072 
Fc 0.842 ± 0.044 0.972 ± 0.071 0.641 ± 0.055 0.856 ± 0.037 0.996 ± 0.093 0.650 ± 0.052 
F1s 0.828 ± 0.030 0.924 ± 0.071 0.616 ± 0.041 0.820 ± 0.036 0.909 ± 0.065 0.599 ± 0.036 
UC 0.808 ± 0.057 0.846 ± 0.092 0.601 ± 0.064 0.812 ± 0.042 0.831 ± 0.076 0.611 ± 0.050 
The results are shown as mean values ± standard errors measured initially (basal values) and after a 21-days application (†). 
UC – untreated controls. 
*For explanation see Methods (Test samples). 
†R2 – the gross – elasticity of the skin including the viscous deformation, and is represented by the ratio of the ability of 
redeformation of skin to final distension; R5 – the biological elasticity (the portion of elasticity compared to the final distension). 
 
Phase I 
In this phase of the study, the following cream samples 
were tested: placebo cream (F1p), active cream containing 
0.4% of ARSC (F1a), cream with 1% of squalene (F1s) and 
commercial cream (Fc) containing the same concentration of 
ARSC as the cream sample F1a. 
In vivo evaluation of irritation potential 
After the 24-h occlusion, there was no statistically sig-
nificant change in EI for any tested cream sample, as well as 
the untreated controls. TEWL was significantly decreased for 
the cream samples F1p and F1a compared to the baseline. 
Also, EC was significantly increased for all active creams 
(F1a, F1s and Fc) compared to the baseline values. 
The in vivo measured parameters (EC, TEWL and EI) 
were expressed as absolute changes (Δ values) compared to 
the baseline (Figure 1). 
In vivo efficacy on normal skin (the long-term 21-day study) 
The results of the long-term 21-day study for EC and 
TEWL are shown as relative percentage change compared to 
untreated control (Figures 2 and 3), while Table 2 shows the 
calculated parameters for viscoelasticity of the skin (R2, R5 
and R7) as mean values ± SD. 
In this part of the study, following positive testing for 
normality, parametric tests were used. Data involving values 
of the parameters measured in the forearm areas treated by 
different samples (F1p through F1s) at distinct time points, 
was analyzed by the one-way within-subjects (repeated mea-
sures) ANOVA, followed by Tukey’s t-test, where appropri-
ate. Differences between the values of the parameters obtai-
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Fig. 3 – The effect of the topical application of the samples† F1p, F1a, Fc and F1s on 
transepidermal water loss (TEWL), related to the untreated control (percentage change). 
Data involving the values of the parameters measured on the forearm areas treated by different 
samples was analyzed by the one-way within-subjects (repeated measures) ANOVA, followed by 
Tukey’s t-test, where appropriate; differences between the values of the parameters obtained for 
the cream-treated skin and the corresponding untreated control were checked by Student’s 
unpaired t-test; all significant differences (p < 0.05) being marked with (*). 
†For explanation see Methods (Test samples). 
ned for the cream-treated skin and the corresponding untrea-
ted control were checked by Student’s unpaired t-test. 
After 14 days of application, although all tested creams 
exhibited a rising trend, skin hydration (measured as the EC), 
it was significantly changed only for the creams F1s and Fc 
compared to the untreated control, whereas after 21 days the 
increase was significant for all active creams (F1a, F1s and Fc) 
(Figure 2).  
The results for TEWL (Figure 3) showed that after 21 days 
of treatment, the TEWL values significantly decreased for the cre-
am F1s compared to all the other tested samples. The investigated 
creams F1a and Fc did not alter TEWL significantly at any time 
point, whereas the cream F1p significantly increased TEWL after 
both 14 days and 21 days of application. 
Phase II 
For the second phase of the study, the following sam-
ples were selected for further investigation: placebo cream 
(F1p), active cream (F1a) with 0.4% of ARSC and the cream 
with 1% of squalene (F1s). In order to evaluate the joint ef-
fects of the investigated actives on previously SLS-irritated 
skin, as well as the concentration dependent impact of 
squalene on the tested skin parameters, two new samples 
were included: active cream with 1% of squalene (F1a1s) 
and the active cream with 6% of squalene (F1a6s) – both 
containing 0.4% of ARSC. 
In vivo efficacy on SLS-irritated skin 
The measured parameters were expressed as absolute 
changes as compared to baseline (Δ values) and presented in 
Figures 4–6. Data from different sites (treated with different 
samples and the controls) at different time points were 
analyzed using one-way ANOVA, followed by Tukey's t-test 
where appropriate. The values of the measured parameters 
after the irritation as well as after six days of the samples’ 
application were compared to both the baseline values and 
between one another using paired sample t-test. The diffe-
rences were accepted as statistically significant at p < 0.05.  
After a 6-day treatment of the SLS-irritated skin, a sig-
nificant decrease in TEWL for all tested creams (F1p, F1a, 
F1a6s, F1s and F1a1s) was seen (Figure 4) when compared 
to the values after irritation ("secondary" baseline values), 
whereas the creams F1a6s and F1s also significantly decrea-
sed TEWL related to the "primary" baseline values. 
As regards skin hydration, measured as EC, after a 6-
day treatment, the creams F1p, F1a6s and F1s significantly 
increased EC related to the values measured after the irritati-
on ("secondary" baseline values) (Figure 5). A trend of EC 
increase, though insignificantly, could be noticed for the tes-
ted creams F1a and F1a1s (Figure 5). 
Furthermore, after 6 days of application, there was no 
significant change in the EI for the creams F1p and F1s, 
whereas the active creams F1a, F1a6s and F1a1s 
significantly increased EI when compared to the "primary" 
baseline values (Figure 6). 
Discussion 
In the initial phase of the study, in vivo evaluation of 
the irritation potential and efficacy during the long-term ap-
plication of the investigated creams was performed on 
healthy skin with two groups of volunteers. 
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Fig. 4 – The effects of the irritation and subsequent topical 
application of the samples† F1p, F1a, F1a6s, F1s and F1a1s 
to irritated skin on transepidermal water loss (TEWL) 
related to the “primary” baseline (absolute changes); both 
controls are also included occluded (UCO) and without 
occlusion (UC). 
The values of the parameters after the irritation (“secondary” 
baseline values) as well as after six days of the samples’ 
application were compared to the “primary” baseline values 
and between one another using paired sample t-test, 
significant differences (p < 0.05) being marked with (*). 
†For explanation see Methods (Test samples). 
 
 
Fig. 5 – The effects of the irritation and subsequent topical 
application of the samples† F1p, F1a, F1a6s, F1s and F1a1s 
to irritated skin on EC related to the “primary” baseline 
(absolute changes); both controls are also included occluded 
(UCO) and without occlusion (UC). 
The values of the parameters after the irritation 
(“secondary” baseline values) as well as after six days of 
samples’ application were compared to the “primary” 
baseline values and between one another using paired 
sample t-test, significant differences (p < 0.05) being marked 
with (*). 
†For explanation see Methods (Test samples). 
 
 
Fig. 6 – The effects of the irritation and subsequent topical application of the samples† F1p, F1a, F1a6s, F1s and F1a1s 
to irritated skin on EI related to the “primary” baseline (absolute changes); both controls are also included occluded 
(UCO) and without occlusion (UC). 
The values of the parameters after the irritation (“secondary” baseline values) as well as after six days of the samples’ 
application were compared to the “primary” baseline values and between one another using paired sample t-test, significant 
differences (p < 0.05) being marked with (*). 
†For explanation see Methods (Test samples). 
The evaluation of the irritation potential, as an impor-
tant safety aspect of cream samples, was conducted under a 
24-h occlusion on the first group of volunteers. In order to 
investigate the irritation potential, EI was monitored. 
Additionally, the potential skin barrier impairment was as-
sessed via TEWL and EC of the skin. 
It is known that occlusion itself induces barrier damage 
without skin dryness, increases penetration of some ingredients 
from topically applied products and may cause irritation 19, 20. 
For that reason, to assess the overall irritation potential, as 
well as the potential skin barrier impairment of the tested 
samples, it was necessary to eliminate the influence of occlu-
Page 998 VOJNOSANITETSKI PREGLED Vol. 73, No. 11 
Filipović M, et al. Vojnosanit Pregl 2016; 73(11): 991–1002. 
sion. Hence, final measurement of the monitored parameters 
was performed 3 h after occlusion removal, when the effects 
of occlusion had subsided 19. 
It was shown (Figure 1) that the EI, as an indicator of 
the skin irritation via the measurement of skin redness 14, was 
not significantly changed compared to the baseline values for 
any cream sample. Also, for the cream Fc and UCO, an insi-
gnificant reduction of the EI related to the baseline could be 
noticed. The rationale for this is probably a prolonged (24-h) 
occlusion and maceration of the skin caused by the increased 
water binding of SC (hyper-hydration of SC) 21, 22. 
As irritants application is often accompanied by the increa-
se of TEWL – a marker of skin barrier function and its structural 
changes – this measurement is commonly used in safety evalua-
tion studies of cosmetic products 2, 3, 20. Although, in our study, 
TEWL showed a falling trend, these results may be considered 
statistically significant only for the placebo cream F1p and the 
active sample F1a. Since there was no significant change in the 
TEWL values on the site reserved for UC, and due to the fact 
that this parameter was significantly increased 3 h after the 24-h 
occlusion on the site reserved for UCO, it could be assumed that 
the obtained results are caused by the effect of the investigated 
active (ARSC incorporated into liposomes). On the other hand, 
if one compares TEWL values for the placebo F1p and the acti-
ve creams F1a and Fc, both containing the same active (the sa-
me concentration and manufacturer of the active), it could be 
speculated that these results can be attributed not only to the car-
rier itself (the cream composition given in Table 1) but also to 
the used emulsifier. The rational for the obtained TEWL results 
is probably the similarity of the liquid crystalline structure of the 
investigated samples (unpublished data) stabilized with the used 
emulsifier to the SC structural organization. This assumption is 
consistent with the already reported results concerning skin mil-
dness and favourable dermatological properties of this type of 
emulsifiers 8–10 and the investigated emulsifier, as well 11. 
As concerns the hydration of the skin (EC), it was increa-
sed in all the treated sites, however, only for the placebo F1p 
without statistical significance. Although occlusion can 
significantly increase SC hydration by blocking water loss from 
the skin surface 20, the obtained results cannot be attributed to 
the occlusion. Since there was no significant change in the EC 
for UCO and the skin hydration on the site reserved for UC was 
decreased (although without statistical significance), the obtai-
ned results can be attributed to the effect of the investigated ac-
tives, as well as the carrier and the used emulsifier, which is 
mainly responsible for the carrier's specific microstructure. 
According to these results no alteration of the skin bar-
rier function occurred. 
The obtained results from this phase of the study 
generally indicated that the investigated cream samples had 
not irritated the skin. The absence of erythema and/or any 
impairment of the skin barrier function in a 24-h occlusion 
study may preliminarily imply the satisfying safety profile of 
the cream samples, as well as of the investigated cosmetic 
actives and the used emulsifier. 
In order to evaluate the efficacy of the investigated 
samples, a long-term 21-day study was performed. After the 
initial baseline measurements, the second group of volunte-
ers with normal/healthy skin was applying the tested samples 
twice a day following the written procedure. The first control 
measurements were performed after a 14-day treatment, and 
the final measurements were conducted a week afterwards. 
As, it is well-known that the short-term application of 
moisturizers may increase hydration of the skin 1–3, EC mea-
surements were conducted to investigate the potential of a 
long-term (21 days) use of the tested creams to hydrate the 
skin effectively. After 21 days of application, all tested acti-
ve creams as well as the placebo sample F1p (although 
without significance) increased the skin hydration level 
compared to UC. It should be emphasized that the creams 
F1s and Fc, effectively changed the EC (a significant increa-
se) as soon as after 14 days of application.  
If one compares the active cream F1a and the commer-
cial one Fc, both containing the same concentration of the 
active (ARSC incorporated into liposomes) but quite a diffe-
rent carrier, it could be assumed that the contribution of the 
investigated active to the moisturizing effect of the creams is 
as important as it was expected. Also, a similar assumption 
could be made by comparing the tested active cream F1a and 
the corresponding placebo F1p, both containing the same 
carrier. However, neither the exact mechanism of the moistu-
rizing effect of ARSC leaves encapsulated in liposomes 
(PhytoCellTec™ Alp Rose) is fully understood, nor their 
ability to eventually penetrate the SC after the application to 
healthy skin. Bearing in mind that the investigated active is 
an extract of the whole cell culture incorporated into liposo-
mes, it could be speculated that the observed hydration effect 
is probably attributed to some ingredients with water binding 
capacity which act like humectants, or to phospholipid-based 
liposomes (physiological lipids) themselves 23. In future re-
search, it would be interesting to investigate the mechanism 
of the observed hydration effect of ARSC incorporated into 
liposomes and their penetration ability, as well. 
Secondly, according to the obtained results, the cream 
containing 1% of olive oil squalene, F1s, increased the EC 
significantly after 14 days, as well as after 21 days of appli-
cation. Thus, if one considers the EC values for the placebo 
F1p and the cream F1s, it could be said that 1% of squalene 
significantly contributes to the cream hydration efficacy. Al-
though, squalene is known as a good moisturizing agent 6, 
the obtained results indicate the possible achievement of ef-
fective skin hydration even at a low concentration of this ac-
tive. On the other hand, there existed a rising trend of the EC 
compared to UC for placebo F1p, although without signifi-
cance, and the lack of statistically significant difference in 
the EC values (skin hydration) between the placebo cream 
F1p and its counterparts – the active samples F1a and F1s. 
Since these samples are based on the same carrier system, 
the recorded results may indicate that for effective skin 
hydration, the carrier itself is beneficial and therefore, 
probably, the used emulsifier as well. This assumption is 
consistent with the previously reported results concerning the 
older generation of APG emulsifiers 8, 10, 24, 25, but also the 
emulsifier used in our study (INCI Simulgreen™ 18–2) 11. 
It is well-known that due to their specific structure, 
water binding capacity and the formation of lamellar phases 
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APG emulsifiers can provide additional skin moisturizati-
on 8, 10, 24, 25. It has recently been reported that creams stabi-
lized with the used novel APG emulsifier may be attributed 
with even stronger water binding capacity in comparison 
with the previous generation of APG emulsifiers. Furthermo-
re, water binding capacity and the formation of liquid 
crystals around oil droplets in creams stabilized with afore-
mentioned emulsifier, depends on the nature of the used oil; 
thus the selection of some non-polar oils (eg, vegetable 
squalane) leads to the visible formation of these structures 11. 
Since squalane is a saturated non-polar derivative of 
squalene, it could be assumed that squalene may also have 
certain impact on the specific colloidal structure of the inves-
tigated cream F1s. Squalene may contribute to both the for-
mation of the lamellar phase in the tested cream sample and 
additional skin moisturization. Within the investigated cream 
samples, especially those containing squalene, anisotropic 
lamellar structure was recorded by polarization microscopy 
(unpublished data), performed during the formulation study 
and the preliminary physical stability investigation of the tes-
ted samples. 
In the case of the impact of a long-term (21 days) use of 
the tested cream samples on the skin barrier, the TEWL mea-
surement was conducted, as the most common method of 
evaluation of the skin barrier function 2. The obtained values 
showed that after 21 days of application, the cream F1s 
significantly decreased TEWL compared to all other tested 
creams. Having compared the placebo F1p which 
significantly increased TEWL after 14 and 21 days of appli-
cation and the cream F1s, it seems reasonable to attribute a 
favourable effect of the active sample to its cosmetic active 
substance (squalene). Taking into account that TEWL mea-
surements are generally used for screening and objective, 
non-invasive perceiving of actives that may have a positive 
effect on the skin barrier function 13, it could be assumed that 
olive oil squalene may even improve the skin barrier functi-
on 2 after long-term application on healthy/normal skin. Fur-
thermore, our findings imply that even a relatively low con-
centration of squalene (1%) significantly contributes to the 
moisturizing efficacy of the tested cosmetic cream (F1s). 
The remaining tested creams F1a and Fc, both contai-
ning the same active (ARSC incorporated into liposomes) 
but a different carrier, did not alter TEWL significantly at 
any time point. The obtained results are consistent with the 
already reported, and indicate that repeated application of 
moisturizers on normal/healthy skin may increase skin 
hydration without affecting TEWL 1. Therefore, it could be 
summarized that a 21-day application of the tested active 
creams, as well as of the investigated active substances (olive 
oil squalene and PhytoCellTec™ Alp Rose) have not resul-
ted in the impairment of skin barrier function.  
On the other hand, the obtained TEWL values for the 
placebo sample F1p are somewhat confusing. The TEWL va-
lues for this sample were elevated after 14, as well as after 
21 days of application, suggesting a possible negative effect 
of the placebo sample on the skin barrier function during a 
long-term use. However, considering that TEWL did not inc-
rease in the case of samples with the same carrier (F1a and 
F1s), and due to the fact that the basal values on the particu-
lar site intended for the application of the sample had already 
been elevated (compared to the UC) with most volunteers, 
the obtained placebo affected TEWL findings could not be 
attributed to the carrier itself. Furthermore, it has been repor-
ted that TEWL on the dominant forearm might be 
significantly higher than on the non-dominant one, and that 
different sites on the same anatomical position might have 
significantly different TEWL values 26. This assumption is 
consistent with our previously obtained results (the lack of 
impairment of the skin barrier function) in a 24-h occlusion 
study for the same sample – placebo F1p. 
To evaluate further the impact of the 21-day application 
of the investigated creams on biomechanical characteristics 
of the skin, the measurement of skin viscoelastic properties 
was conducted, as well. It is widely acknowledged that the 
ageing process alters structural and mechanical properties of 
the skin through changes of the elastic and collagen fibers. 
As ageing is accompanied by a decrease of skin elasticity 
which begins in the early twenties, this measurement could 
be useful for the study of the influence of the investigated 
samples on biomechanical characteristics of the skin. 
Viscoelasticity of the skin was assessed with a calibrated Cu-
tometer® MPA580, suction-based instrument equipped with a 
2-mm-diameter probe. Applying the following settings: 400 
mbar suction pressure, suction time 2 s, relaxation time 2 s, 3 
repetitions, the skin deformation curve (a deformation vs ti-
me curve) was obtained. This curve offers two types of pa-
rameters: directly measured from the curve so-called U-
parameters (total deformation recovery Ua, total extensibility 
Uf, immediate elastic deformation Ue and immediate elastic 
recovery Ur, which are the most commonly used U-
parameters) and calculated so-called R parameters (R0 to R9 
parameters). R-parameters were calculated using the 
Software Cutometer® MPA580, but for the evaluation of vi-
scoelastic properties of the skin only a few were chosen: R2 
(Ua/Uf), R5 (Ur/Ue) and R7 (Ur/Uf). The parameter R2 
(gross elasticity) reflects the overall elasticity of the skin, R5 
(net elasticity) reflects only the elastic component of the vis-
coelastic response of the skin (it is affected solely by the ela-
stic fibers of the skin), while the parameter R7 represents the 
elastic recovery ratio and it can be affected by changes of 
elasticity and viscosity of the skin. These parameters were 
calculated as those unaffected by skin thickness of the volun-
teers and the experimental conditions of the study. Moreover, 
they were the most useful for this type of the study, 
especially the parameter R7 which is most closely related to 
the skin elasticity and has profound meaning for measuring 
skin ageing by evaluating its elasticity 27. As it could be seen 
(Table 2) after 21 days of application, there was no signifi-
cant change in the selected parameters. Hence, the obtained 
results indicate that the investigated creams do not have an 
impact on skin elasticity after a 21-day application to the 
skin of volunteers in their early twenties. This findings may 
suggest a few possible implications: selection of a proper 
group of human volunteers is of paramount significance to 
detect possible effects, if any, of the treatment that could 
tentatively be define as anti-age skin improvement; claims 
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indicating anti-age plant stem cells effect have to be suppor-
ted by a set of adequate objective and subjective 
techniques/methods of evaluation; proper concentration ran-
ge and the type of the vehicle/carrier system adjusted for the 
given active is always the most important task for a formula-
tor attempting to achieve both a satisfying efficacy and an 
acceptable safety profile of a skin care product. 
Overall, upon consideration of the obtained results from 
the first phase of our study, it was shown that the tested cre-
ams stabilized with a novel APG emulsifier have satisfying 
safety profiles, either with or without the incorporated active 
substances (1% of olive oil squalene (Olifeel® SQ) and 0.4% 
of ARSC leaves encapsulated in liposomes (PhytoCellTec™ 
Alp Rose)). In addition to this, after a long-term use (21 
days) on healthy skin, these creams manage to increase SC 
hydration without compromising the skin barrier function. 
Finally, this study stage proved that the investigated actives, 
especially olive oil squalene, are efficient, indicating that 
they could be appropriate actives for cosmetic moisturizers 
intended for healthy skin care. 
It is widely acknowledged that the application of the 
effective moisturizers – those with a proper composition 
and with adequate cosmetic actives in optimal contents, co-
uld have a positive impact on the renewal of the (SLS)-
irritated skin 1, 11, 24, ie it may have a general favourable ef-
fect on the recovery of irritated skin. So, as to investigate 
the potential of the tested creams further, in the second 
phase of the study the samples were evaluated upon their 
application to the previously irritated skin, again employing 
non-invasive measurements of the predetermined skin pa-
rameters throughout the study. To perform this, an in vivo 
skin irritation test with 10% SLS aqueous solution under a 
6-h occlusion was performed in the following manner. Ini-
tial basal values were taken before ("primary" basal values) 
and after ("secondary" basal values) the SLS solution was 
applied and the occlusion was placed on the investigated 
skin sites. In order to eliminate the influence of occlusion 
itself and determine the effects of SLS, the "secondary" ba-
sal values were measured 24 h after the irritation test and 
the occlusion removal 19. TEWL values (in more than 50% 
of volunteers TEWL greater than 12 g/m2h1 was recorded), 
confirmed that skin dryness was successfully induced 16. 
Final measurement was conducted after 6 days of treatment 
with the tested creams. 
Non-invasive skin biophysical measurements are 
widely used in the assessment of skin irritation elicited with 
SLS as a model irritant. In addition to the TEWL measure-
ment, which is a highly sensitive and precise method for the 
determination of SLS irritation effects on the skin, as well as 
the most valid measurement for assessment of low irritant 
skin reactions, it is also useful to monitor hydration of the 
skin (EC) and EI 17, 19. 
After the 6-day treatment of the SLS-irritated skin, 
TEWL was significantly decreased for all investigated cre-
ams (F1p, F1a, F1a6s, F1s and F1a1s) related to the 
"secondary" basal values (values measured upon irritation) 
(Figure 4). Secondly, for the creams F1a6s (containing 
ARSC and 6% of squalene) and F1s (containing 1% of 
squalene), a significant decrease in TEWL could be noticed 
when compared to the "primary" baseline (normal skin prior 
to irritation). Although TEWL was significantly decreased 
for the induced UCO related to the "secondary" baseline, the 
results obtained at the treated sites could not be solely attri-
buted to the physiological regeneration of the skin, especially 
regarding the creams F1a6s and F1s. For the creams F1a6s 
and F1s, the obtained TEWL values could also be addressed 
to squalene and the carrier itself. After the application of the 
aforementioned samples, squalene may remain on the skin 
surface and due to the skin occlusion it may decrease TEWL 
or even penetrate the skin and influence its barrier recovery 3. 
On the other hand, stabilized with a novel APG emulsifier, 
the carrier itself may contribute to the skin barrier recovery 
after the application on SLS-irritated skin as well, which has 
already been reported for vehicles based on this type of 
emulsifiers 24. Such results indicate that both the investigated 
creams and tested actives may have a positive effect on skin 
barrier integrity. This assumption is consistent with the re-
ported results regarding moisturizers and their impact on the 
skin barrier recovery after exposure to SLS 3, 24. 
When it comes to skin hydration, a significant change 
of the EC compared to the "secondary" basal values was de-
tected (Figure 5) for the placebo sample F1p and the active 
creams F1a6s and F1s. Namely, the EC value for UCO after 
6 days remained significantly lower compared to the 
"primary" baseline. Thus, the trend of the EC increase, 
however insignificant, caused by the skin treatment with 
both the F1a and F1a1s creams, might be interpreted as the 
contribution in hydration effect of the tested actives. Moreo-
ver, these results are in line both with those from the 21-day 
study and with our initial assumption that the carrier itself 
contributes to the skin hydration, and presumably together 
with the used emulsifier as well. 
As concerns EI values, after the 6-day application of the 
tested creams there was no significant change in the EI for 
the placebo cream F1p or the active cream F1s in relation to 
the "primary" basal values, although the trend of the EI dec-
rease could be observed compared to the "secondary" baseli-
ne (values measured upon irritation) (Figure 6). Secondly, 
for the cream sample F1a and the samples containing a com-
bination of the actives F1a1s and F1a6s, the EI values were 
elevated compared to the "primary" baseline, whereas for the 
samples F1a1s and F1a6s the trend of the EI decrease com-
pared to "secondary" basal values (values measured upon ir-
ritation) could be observed as well. These results may imply 
at least two possible scenarios: adverse effect of the tested ac-
tive (ARSC incorporated into liposomes) on previously irrita-
ted skin; too short period left for skin regeneration even under 
the treatment. On the other hand, after 6 days of treatment, the 
EI value remained significantly increased for the induced UC 
(UCO) compared with the "primary" baseline, and the trend of 
the EI increase was noticed related to the "secondary" basal 
values. Regarding the results for UCO and the fact that the re-
duction of skin irritation without adverse effects has recently 
been ascribed to ARSC by some researchers 28, it can be spe-
culated that the obtained results are somehow a consequence 
of SLS irritation and occlusion itself. 
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The results of the second phase of the study generally 
stand in good agreement with the results of the first phase. 
The tested creams and the incorporated actives per se exerted 
a positive effect on irritated skin and they proved to have the 
potential to renew certain skin damages. The fact that 
hydration of the skin was elevated after the application of all 
investigated samples (for F1a and F1a1s without any statisti-
cal significance) suggests the contribution of the investigated 
actives, the carrier and its specific colloidal structure, and it 
consequently implies that the used emulsifier contributed to 
the observed moisturizing effect. Finally, the tested actives 
proved to be efficient in the treatment of irritated, dry skin. 
Additionally, regarding the creams containing a combi-
nation of the actives and different concentrations of squalene 
(F1a1s and F1a6s, containing 1% and 6% of squalene, 
respectively), the study shows a concentration-dependent impact 
of squalene on skin hydration. Although, squalene is considered to 
be a good emollient and moisturizing agent 6, the obtained results 
also imply a certain impact on the specific colloidal structure in 
the tested creams, probably due to the formation of the lamellar 
phase, resulting in the additional skin moisturization. 
Conclusion 
With the use of non-invasive skin biophysical measu-
rements, the performed study confirms that the investigated 
actives – Alp Rose stem cells incorporated into liposomes 
and olive oil squalene, as well as the used emulsifier – 
hydroxystearyl alcohol and hydroxystearyl glucoside, show 
no irritation potential, nor any negative influence on the skin 
barrier function during the application on healthy or irritated 
skin. In view of these results, it could be said that these in-
gredients can be safely applied in the formulation of cosmetic 
moisturizers. The present study also shows a good skin 
hydration potential of the tested actives used either on the 
healthy or irritated skin. Furthermore, our results imply that 
both actives can be used for the improvement of skin barrier 
function. In addition, considering the lack of impact on skin 
elasticity after the application of the investigated samples, our 
study failed to show the potential anti-age skin improvement 
effect of the tested actives, probably due to the inappropriate 
selection of young volunteers in their early twenties. 
Therefore, Alp Rose stem cells incorporated into lipo-
somes, olive oil squalene and hydroxystearyl alcohol and 
hydroxystearyl glucoside could be used both alone and com-
bined in moisturizing formulations intended for normal and 
dry skin care, whereas olive oil squalene could be used for 
treatment of irritated or sensitive skin as, well. 
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